GlaxoSmithKline PLC Director/PDMR Shareholding (0581X)
May 03 2016 - 6:28AM
UK Regulatory
TIDMGSK
RNS Number : 0581X
GlaxoSmithKline PLC
03 May 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibility or Connected Persons
In accordance with DTR 3.1.4R (1) (a) I give details of changes
in the interests of Emma Walmsley, a Person Discharging Managerial
Responsibilities, in the Ordinary Shares of GlaxoSmithKline plc
(the "Company") following the exercise of nil cost options over
14,789 and 5,583 Ordinary Shares on 29 April 2016, granted on 28
February 2013, which vested on 28 February 2016 under the
GlaxoSmithKline Deferred Annual Bonus Plan. The Company delivered
the net of tax value in shares being 10,605. The fair market value
of an Ordinary Share at the points of exercise on 29 April 2016 was
GBP14.78 and GBP14.79 respectively.
The Company and Emma Walmsley were advised of these transactions
on 3 May 2016.
V A Whyte
Company Secretary
3 May 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHBXLFBQEFLBBD
(END) Dow Jones Newswires
May 03, 2016 06:28 ET (10:28 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024
